We previously reported that BARF1 gene has either an immortalizing effect, when expressed in primary primate epithelial cells, or a malignant transforming activity, when expressed in established and nontumoral rodent fibroblast or human B-cell lines. As predicted from sequence analysis, we found that BARF1 coded protein can be secreted from different cell lines, among them BARF1-transfected Balb/c3T3 rodent fibroblasts. Thus, as an initial step to clarify BARF1 oncogenic functions, we investigated whether the secreted form of BARF1 protein can activate the cell cycle as a growth factor. Since efficient BARF1 expression could be obtained from 293-tTA cells infected with a tetracycline-regulatable recombinant adenovirus, secreted BARF1 product could be purified from the culture medium of such cells by ammonium sulfate precipitation, ion exchange chromotography and sucrose gradient sedimentation. We describe in this paper that addition of a purified product of secreted BARF1 protein to serum-free culture medium of Balb/ c3T3 rodent fibroblasts, human Louckes B-cell line and primary monkey kidney epithelial cells resulted in a cell cycle activation that was inhibited by affinity-purified anti-BARF1 antibody. Our demonstration of a specific stimulation of cell cycle in vitro by BARF1 secreted product suggests that this EBV-encoded BARF1 protein could act as a growth factor in vivo.
Introduction
The Epstein-Barr virus (EBV) is associated with several human cancers, particularly Burkitt's lymphoma, nasopharyngeal (NPC) and gastric carcinoma (Rickinson and Kieff, 2002) . At least six genes, EBNA1, EBNA2, EBNA3A, EBNA3C, LMP1 and EBERs, are indispensable for B-cell immortalization (Kieff, 1996) . Recent data showed that human as well as simian primary epithelial cells could be infected and immortalized by EBV in vitro (Nishikawa et al., 1999; Danve et al., 2001) . However, EBV genes that are indispensable for epithelial cell immortalization are not well known. EBVimmortalized epithelial cells expressed EBNA1, EBERs, LMP 2A, BARF1 and BARF0 genes (Nishikawa et al., 1999; Danve et al., 2001) .
We recently discovered that the introduction of BARF1 in primary monkey kidney epithelial cells rendered to cell immortalization . BARF1 was expressed in EBV-immortalized epithelial cells without expression of LMP1 (Danve et al., 2001) . BARF1 gene was capable of inducing a malignant transformation in Balb/c3T3 cells (Wei and Ooka, 1989) as well as in the established (but not tumoral) human Louckes and Akata B-cell lines (Wei et al., 1994; Sheng et al., 2003) . A recent study showed that BARF1 gene transfection resulted in growth activation of monkey epithelial cells, where the viral sequence was specifically localized in double minute chromosomes (Gao et al., 2002) . It therefore appeared that BARF1 was implicated not only in cell immortalization but also in cell malignant transformation (Ooka, 2001) . Its 54 first amino acids were sufficient to both induce cell malignant transformation and activate Bcl2 expression (Sheng et al., 2001) . Bcl2 activation was also observed in EBVnegative human Akata B cell transfected by BARF1 (Sheng et al., 2003) . BARF1 expression has been reported in almost 90% of both gastric (Zur Hausen et al., 2000) and nasopharyngeal carcinoma biopsies (Sbih-Lammali et al., 1996; Hayes et al., 1999; Decaussin et al., 2000) .
Considering all the information, BARF1 gene could likely have an important role in malignancies of epithelial cells. However, the oncogenic mechanism induced by BARF1 is not yet known.
BARF1 protein could play a role as a soluble receptor for human colony-stimulaing factor 1 (CSF-1) (Strockbine et al., 1998) and could regulate immune response by inhibiting Alpha interferon secretion from mononuclear cells (Cohen and Lekstrom, 1999) . On the other hand, BARF1 has been shown to serve as a target for antibody-dependent cellular cytotoxicity (ADCC) (Tanner et al., 1997) . These observations suggest that the biological activity of BARF1 might concern immunomodulation besides oncogenicity. Computer analysis of BARF1 sequence predicted a cleavage site after the 20th N-terminal amino acid. The secretion of a 29 kDa BARF1-coded polypeptide from human B cells was already reported by Strockbine et al. (1998) and confirmed from different cells in our laboratory, where the exact cleavage site was 20th amino acid (de TurenneTessier et al., submitted) . Almost all BARF1 protein is secreted in culture medium rendering its detection difficult in intracellular compartment. Our previous data showed that the molecular weight of the BARF1 protein detected in the cell extract was 31-33 kDa. This is likely a result of the noncleaved form of BARF1 protein before secretion.
One possible mechanism of oncogenic transformation induced by BARF1 might be autocrine/paracrine cell cycle activation by the secreted form of its translation product.
Therefore, we examined the ability of BARF1 secreted product to activate DNA synthesis and cell growth in vitro. Efficient BARF1 expression from a tetracyclineregulatable recombinant adenoviral system allowed us to purify BARF1 secreted product from 293-tTA cell culture medium. As shown here, addition of purified BARF1 secreted protein to serum-deprived culture medium, resulted in a specific activation of the cell cycle of not only Balb/c3T3 rodent fibroblastes but also human B-cell line and primary monkey kidney epithelial cells. This result supports the hypothesis that BARF1 secreted product might have cell growth factor functions in vivo.
Results
Synthesis of BARF1 product from a eukaryotic expression system allowed the purification of the secreted form of the protein, which was examined for cell growth stimulating activity on murine fibroblast culture in vitro.
Production of BARF1 protein by recombinant adenovirus
We found a tetracycline-regulatable adenoviral system able to stabilize and efficiently express BARF1: it was based on 293-tTA cell infection by rAd/B-G recombinant adenovirus, isolated after insertion of BARF1 into the dicistronic pADTR5-DC/GFP vector ( Figure 1a ). As shown in Figure 1b , direct immunofluorescence observation of live cells at 15-18 h postinfection with rAd/B-G, revealed almost 100% green fluorescent protien (GFP) positive cells, suggesting convenient BARF1 expression level.
SDS-PAGE analysis following by Coomassie blue gel staining showed the presence of a thick 29 kDa band only in rAd/B-G (lane 1) (not in rAd/G: lane 2)-infected cell medium, and immunoblot analysis with anti-BARF1 antibody (lanes 3 and 4) gave a positive response at this level only (Figure 1c ). The quantity of secreted BARF1 protein (p29) was estimated to vary between 10 and 30% of total culture medium protein. This adenoviral expression system was shown to allow efficient secretion of a cleaved form of the BARF1 protein.
The native structure of secreted BARF1 protein was analysed by a 5-40% linear sucrose gradient. A gradient with concentrated p29-containing medium as well as two similar gradients, respectively, loaded with bovine serum albumin (BSA:4.4S and 67 kDa) and immunoglobulin G (IgG:7.0S and 150 kDa) used as references were centrifuged. Analysis of refractometry and optical density at 280 nm (Figure 2) showed sedimentation of both BSA and IgG. The p29 was mainly revealed around 8S (about 180 kDa for a globular protein) by immunoblot detection with anti-BARF1 antibody (see the inset). Native BARF1 secreted product sediments faster than IgG on linear sucrose gradient, as a large stable molecule with potential oligomeric structure.
Purification of secreted BARF1 protein
In order to test whether the secreted BARF1 protein can act as a cell-stimulating factor, rAd/B-G-infected 293-tTA cell medium was subjected to three sequential steps of purification: ammonium sulfate precipitation, ion exchange chromatography and sucrose gradient sedimentation. The fractions from the HiTrap Q Sepharose Fast Flow column were analysed by SDS-PAGE. As illustrated in Figure 3a , Coomassie blue gel staining showed most p29 in the 19-21th fractions. Fractions Figure 1 (a) pAdTR5-DC/GFP transfer plasmid with dicistronic expression cassette. This vector was derived from pAdTR5 and pAdCMV5 (Massie et al., 1998) . BARF1 sequence was cloned in Bgl II site, under the control of a tetracycline-regulated promoter, and recombination with E1/E3-deleted Ad5 DNA allowed the isolation of BARF1/GFP carrying recombinant adenovirus: rAd/B-G. Silver staining attested to the presence of very few contaminant proteins, with the p29 almost solely detected by Coomassie blue in this fraction, in which BARF1 protein purity level was estimated to be higher than 95%. It must be noticed that BARF1 protein sedimentation coefficient was found unchanged by the purification procedure here used.
Specific mitogenic activity of purified BARF1 protein
Balb/c3T3 cells were cultured in a 96-well plate with complete medium with 10% fetal calf serum (FCS). Cells were then incubated in DMEM either without FCS, with 10% FCS or with 200 ng pure p29 protein.
Cell activation was examined by the MTT assay after 48 h. As shown in Figure 4a , the cell metabolic activity was efficiently stimulated in the presence of 200 ng pure BARF1 protein. The addition of 10% FCS used as a positive control led to a high level of response for the MTT test. Interestingly, the level of cell cycle activation was significantly higher than that of 10% FCS. To check that this effect was really due to BARF1 product, the test was repeated by adding an affinity-purified fraction of rabbit antibody anti-Pep-2B (Decaussin et al., 2000) . As also illustrated in Figure 4a , the cell activation induced by 200 ng protein from purified p29 fraction was efficiently inhibited in the presence of 4 ml of anti-Pep-2B. The MTT value become almost as a negative control (without FCS). We also tested 293 cell medium infected In all, 30 ml of each fraction (200 ml) was analysed by SDS-PAGE in 12% polyacrylamide gel. Coomassie blue gel staining mainly detected p29 in the 25th fraction. (c) Silver gel staining of sucrose gradient fractions. SDS-PAGE performed as described in b was followed by silver staining to examine p29 contamination by less abundant proteins undetected by Coomassie blue gel staining. Silver staining confirmed the 25th sucrose gradient fraction as a purified BARF1 protein fraction We then analysed specific mitogenic activity of p29 protein on human Louckes B-cell line (which could be transformed by BARF1 gene: Wei et al., 1994) and primary monkey kidney epithelial cells (which could be immortalized by BARF1 gene: Wei et al., 1997) . As illustrated in Figure 4b ,c, p29 protein could activate cell cycle of both cells as observed in rodent fibroblast. In both cases, mitogenic activity with p29 was higher than those obtained with 10% FCS used as a positive control. These observations suggest that p29 protein has a powerful cell cycle activation property.
These results attest that cell activation induced in the presence of purified p29 protein from rAd/B-G-infected cell medium, is specifically due to the secreted form of BARF1 protein.
Expression of BARF1 protein by BARF1-transfected Balb/c3T3 cells
Since the above-reported data suggested that secreted BARF1 protein could act as a cell growth factor, we looked for p29 secretion by BARF1-transfected Balb/ c3T3 cells, as a first step in investigating the method(s) used by BARF1 for oncogenic transformation of these cells (Wei and Ooka, 1989; Sheng et al., 2001) . We thus analysed BARF1 protein expression by two BARF1-transfected Balb/c3T3 cell clones (c55-C2 and c55-C3) at the active cell growth stage, in comparing crude cellular extract (E) and culture medium (M). As illustrated in Figure 5 , the culture medium from both clones (lanes 3 and 4) was clearly found to contain a 29 kDa BARF1 product, while no BARF1 protein was immunodetected in crude cell extract of two clones (lanes 5 and 6). This suggested that BARF1 translation product did not accumulate inside actively growing cells, but was rapidly cleaved and secreted in culture medium. A small amount of intracellular BARF1 protein could be detected from BARF1-transfected Balb/c3T3 cells only when they were (a) Balb/c3T3 cells were cultured in a 96-well plate (10 4 cells/100 ml complete medium) till 60-70% confluence, washed with PBS, and incubated in 100 ml serum-free medium containing either 200 ng purified p29 protein (p29s) or p29 with 4 ml of affinity-purified anti-BARF1 antibody (p29 þ anti-BARF1). After 48 h incubation, the MTT assay was performed as usual. The addition of 10% FCS was used as a positive control (10% FCS). Negative control consisted in cells cultured with serum-free DMEM only (0% FCS). (b) Human Louckes B-cells (Wei et al., 1994) were cultured in a 96-well plate (10 4 cells/100 ml complete medium) and washed with PBS, then incubated in 100 ml serum-free medium containing 200 ng pure p29 (p29s). Positive and negative controls are the same as (a). (c) Primary monkey kidney epithelial cells were cultured in a 96-well plate (10 4 cells/100 ml complete medium) with DMEM plus EGF till 60-70% confluence, washed with serum-free DMEM, then with PBS, and incubated in 100 ml serum-free medium containing 200 ng protein from pure p29. Positive and negative controls are the same as (a) at the stationary stage (from confluent culture) (C2E). As it had an apparent molecular weight around 31-33 kDa (lane 1), this protein, which was undetectable from negative control Balb/c3T3 cells (lane 2), should correspond to the entire (uncleaved) form of BARF1 translation product.
Discussion
We reported that BARF1 protein was released in culture medium not only by epithelial cells but also by rodent fibroblasts. When BARF1 protein expression by BARF1-transfected Balb/c3T3 cells was carefully examined by SDS-PAGE (Figure 5 ), it appeared that, when cells entered the stationary phase (confluence reaching culture), a 31-33 kDa BARF1 product was observed in crude cell extract, while from actively growing culture, BARF1 protein was undetectable inside cells and (almost) all found in culture medium as 29 kDa polypeptide. These observations suggested rapid cleavage and secretion of BARF1-translation product by actively growing rodent fibroblasts and 293 epithelial cells. Secretion of 29 kDa BARF1 polypeptide has, moreover, been detected from human B-cell lines (Strockbine et al., 1998) . While a 29 kDa polypeptide is obtained after denaturation of secreted BARF1 product in SDS-PAGE conditions, sucrose gradient sedimentation of the native protein revealed an apparent molecular weight around 180 kDa, and we actually are investigating whether such a structure results from p29 oligomerization and/or association with other components.
Our main objective here was to examine whether the mechanism of the cell growth activation observed after BARF1 transfection (Wei and Ooka, 1989; Karran et al., 1990; Wei et al., 1994 Wei et al., , 1997 Sheng et al., 2001 Sheng et al., , 2003 Gao et al., 2002) could be autocrine activity of the secreted BARF1 protein. Using both the MTT metabolic assay and DNA synthesis analysis, we demonstrated cell cycle activation of Balb/c3T3 fibroblasts, human B-cell line and primary monkey kidney epithelial cells, when purified fractions of secreted BARF1 protein were added to serum-free culture medium. Neutralization assay using an almost pure sample of BARF1 protein and an affinity-purified anti-BARF1 antibody confirmed that cell-stimulating activity induced by p29 obtained from culture medium was actually due to BARF1 secreted product. This result thus suggests that the protein could induce cell growth transformation and/or cell gene activation in cells through an autocrine/paracrine process.
Intracellular BARF1 protein was detectable by immunoblotting as a 31-33 kDa polypeptide only in stationary cultures of transfected rodent fibroblasts ( Figure 5 ) or human epithelial cells (Liu and Ooka, in preparation) . BARF1 expression has been reported in human epithelial tumor cells from both NPC and gastric carcinoma (Sbih-Lammali et al., 1996; Hayes et al., 1999; zur Hausen et al., 2000; Decaussin et al., 2000) . While we could reveal BARF1 translation in NPC epithelial cells (Decaussin et al., 2000) , we have had more difficulties in revealing BARF1 protein in BARF1-transfected B cells or EBV-positive BL cell lines. At the transcriptional level, however, BARF1 expression was easily detectable by RT-PCR in human BL cell lines established for a long time, such as P3HR-1 and AKATA as well as in other latent B cell lines like Namalwa and IB4 cell lines (only containing 1-2 copies of EBV genome/cell), when analysed by RT-PCR using cytoplasmic polyA RNA. This suggests that these latent cell lines expressed functional BARF1 messenger RNA; since BARF1 translation in these cells was still very difficult to reveal by immunoblotting, BARF1 protein might be actively secreted and thus too poorly abundant intracellularly to be detectable on blot. As BARF1 transcription was demonstrated in almost all biopsies of EBV-induced lymphoma from tamarin (Zhang et al., 1992) and BL from African Malawi region , BARF1 might be involved in B-cell cycle activation. The activation of human Louckes B-cell cycle by pure p29 (Figure 4b ) reinforces this hypothesis. Interestingly, we observed that immunoblotting detection of BARF1 protein was possible in EBV-positive Akata cell-induced murine tumors (Sheng et al., 2003) , but almost impossible from EBV-positive Akata B cell cultures, where 1-2% of cells express lytic antigens.
BARF1 could stimulate several cell protein expression: Bcl2, c-myc, CD21, CD23 and CD71 (Wei et al., 1994; Sheng et al., 2001 Sheng et al., , 2003 . We, however, do not know whether such cellular genes' activation is performed by intracellular BARF1 protein and/or via cell stimulation by secreted BARF1 product.
As BARF1 has been involved in ADCC activity (Tanner et al., 1997) , CSF1-binding and neutralization (Strockbine et al., 1998) and inhibition of IFNa secretion (Cohen et al., 1999) , BARF1-induced oncogenic transformation might result from immunomodulating functions of BARF1 protein protecting EBV existence. Potential roles of intracellular and secreted forms of the protein in these process have to be determined and identification of BARF1 secreted protein receptor(s) now seems to be of much importance for understanding BARF1 functions in vivo.
Materials and methods

Cells and cell culture
Balb/c3T3 cells and 293-tTA (tetracycline regulatable) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Sigma) supplemented with 10% FCS and antibiotics as described previously (Sheng et al., 2001) . Primary monkey kindney epithelial PATAS cells were cultured in DMEM with EGF (Danve et al., 2001 ) and human Louckes B-cell line was cultured in RPMI 1664 (Sigma) with 10% FCS (Sheng et al., 2003) .
BARF1-GFP recombinant adenovirus
BARF1 sequence was cloned at the Bgl II site of the dicistronic pAdTR5-DC/GFP transfer plasmid containing a tetracyclineregulated promoter ( Figure 1a ) (Massie et al., 1998) . This transfer plasmid linearized by Fse I was cotransfected with the E1/E2-deleted Ad5 backbone viral DNA into 293 cells. Adenovirus plaques were screened for BARF1 protein by Western blot. One positive BARF1-GFP recombinant adenovirus, rAd/B-G, was plaque purified and amplified in 293 cells. Following freeze/thawing cycles, the rAd/B-G viruses present in the supernatant were purified on two successive CsCl gradients, and titered by plaque assay. This parent virus (10 8 PFU/ml) was amplified in 293-tTA cells, and each new viral progeny was titered by plaque assay.
BARF1 protein production 293-tTA cells were cultured in a 100-mm plate with 10 ml of DMEM containing 10% FCS till 60% of confluence. Cells from 25 plates were harvested with trypsine and centrifuged at 800 g. The pellet was washed twice with DMEM without FCS, then suspended in 10 ml of DMEM without FCS. Infection with rAd/B-G was performed at 1.2 Â 10 6 PFU/10 6 cells for 1 h rotation at 371C. The cell suspension was then seeded at 20 Â 10 6 /100-mm plate in 8 ml of DMEM with 10% FCS. After incubation for 24 h, the cell culture was washed four times with DMEM without serum, then added with 5 ml of DMEM without FCS and further incubated for 24 h. The cells were then pelleted for 20 min at 2000 g, and the culture medium was saved. After elimination of virus and cell debris by 2 h ultracentrifugation at 167 000 g, the 250 ml cleared culture medium was reduced to 10 ml final volume by concentration in Vivacell 250 (Vivascience) followed by centrifugation in Biomax-10 Ultrafree-15 filter device (Millipore). This concentrated fraction was used for BARF1 protein purification.
Purification of secreted BARF1 protein
At first, the concentrated culture medium was precipitated by 50% ammonium sulfate and centrifuged at 8000 g for 25 min (Beckman J2-21, rotor JA20). The pellet was dissolved and dialysed overnight in TD buffer: 20 mM Tris, pH 8.5, and 5 mM dithiothreitol (DTT). Further purification was performed with HiTrap Q sepharose Fast Flow (Amersham). The column was equilibrated with TD buffer, loaded with 5 ml protein sample and washed with TD buffer. Elution was carried out with a linear gradient of 0-1 M NaCl in TD buffer. Immunoblot analysis of the fractions showed that BARF1 protein was eluted at 25 mM NaCl, and mainly recovered in fractions 19-21. These fractions were pooled, dialysed against TD buffer and loaded on 5 ml of a 5-40% linear sucrose gradient. After gradient ultracentrifugation at 105 000 g for 16 h, 200 ml for each fraction were collected. BARF1 protein was localized by immunoblot, and its purity was examined using both EZBlue (Sigma) and silver staining (BioRad).
Mitogenic activity analysis
Cell growth assay Cell proliferation and viability were tested using the MTT assay (Cell proliferation kit I; Roche, Germany) based on the spectrophotometric measurement of formazan enzymatically formed from tetrazolium salts by metabolically active cells. Cells were seeded at 10 4 cells/well in 96-well culture plates (Falcon; Becton Dickinson Labware), and cultured in 100 ml DMEM (Balb/c3T3 and PATAS) or RPMI 1664 (Louckes B cells) with 10% FCS till 60-70% confluence. The culture medium was then discarded, and the cells were washed four times with phosphate-buffered saline (PBS). Each well then received 200 ng of purified BARF1 protein included in 100 ml serum-free DMEM. At 48 h of culture, 10 ml MTT solution was added per well. After 4 h incubation, colored crystals of formazan were dissolved overnight at 371C with 100 ml solubilization solution, and optical density was measured at 600 nm.
DNA synthesis assay on Balb/c3T3 The cells were seeded into 96-well culture plates at 10 4 cells/well in DMEM with 10% FCS. When the culture reached 60-70% confluence, the cells were washed four times with PBS, then received 0.1 ml/well of serum-free DMEM containing 200 ng of purified BARF1 protein and 2 mCi [ 3 H]thymidine. The cells were collected by trypsinization after 48 h incubation at 371C. DNA labelling was measured; in short, one volume of 20% cold trichloroacetic acid (TCA) was added to 0.5 ml cell suspension for 30 min contact in cold ice, then the cell extract was filtered on GF/C Whatman paper discs, and retained radioactivity was measured with a Scintillation Analyzer (Tri-Carb 2100 TR, Packard).
Mitogenic activity neutralization assay on Balb/c3T3 cells To assure that the cell growth activation observed after addition of a purified BARF1 product to Balb/c3T3 fibroblast culture medium was actually due to the BARF1 protein itself, the mitogenic activity of our purified fraction was further examined in the presence of anti-BARF1 antibody. Balb/ c3T3 fibroblasts were seeded into a 96-well plate at 10 4 cells/ well, and when the culture reached 60% confluence, the cells were washed with PBS, then further incubated in 100 ml serumfree DMEM containing 200 ng of purified BARF1 protein, added or not with 4 ml of 'anti-Pep-2B' antibody raised against the NGGVMKEKD peptide (a.a.172-180) of BARF1 protein (Tanner et al., 1997; Decaussin et al., 2000) ; this antibody was obtained by affinity purification of rabbit antiserum on an NGGVMKEKD peptide-coupled column (Neosystem, Strasbourg, France). The MTT assay was carried out as described above after 48 h incubation.
Analysis of BARF1 protein expression by BARF1-transfected Balb/c3T3 cells Balb/c3T3 cells were transfected with BARF1 gene as previously described (Sheng et al., 2001) . Two BARF1-positive clones, c55-C2 and c55-C3, were cultured in 100 mm plates at 6 Â 10 6 cells/10 ml for 48 h in serum-free DMEM. Cells and culture medium were then harvested by centrifugation at 2000 g. Crude cell extracts were prepared as previously described (Decaussin et al., 2000) , and 50 ml medium was concentrated to 100 ml as described above for 293-tTA cell medium. SDS-PAGE analysis of both clone protein expression was performed by loading either 10 mg protein from concentrated culture medium, or 40 mg protein from crude cell extract, per well of a 12% polyacrylamide gel. Electrophoresis was followed by protein transfer onto nitrocellulose, and immunodetection with anti-Pep-2B antibody.
Immunoblotting
Proteins quantitated by the Bio-Rad Protein Assay (Bio-Rad Laboratories, Inc.) were diluted with one volume of gel sample buffer (0.2% bromophenol blue, 4% SDS, 200 mM DTT, 20%
glycerol, 125 mM-Tris-HCl, pH 6.8), and boiled for 5 min. Protein samples were separated on 12% polyacrylamide denaturing gels, blotted on to reinforced nitrocellulose, and immunodetected as previously described (Decaussin et al., 2000; Sheng et al., 2003) . BARF1 protein visualization was obtained by overnight blot incubation at 41C with anti-Pep-2B, 1 h incubation at room temperature with peroxidaselabeled anti-rabbit Ig, and enhanced chemiluminescence (SuperSignal West Pico Chemiluminescent Substrate, Pierce).
